These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8028630)

  • 1. Adjuvant systematic therapy and survival after breast cancer.
    Evans RA
    N Engl J Med; 1994 Aug; 331(6):403; author reply 403-4. PubMed ID: 8028630
    [No Abstract]   [Full Text] [Related]  

  • 2. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial results appear consistent with real-life outcomes in British Columbia.
    Susman E
    J Natl Cancer Inst; 2005 Feb; 97(3):170. PubMed ID: 15687359
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant systemic therapy and survival after breast cancer.
    Olivotto IA; Bajdik CD; Plenderleith IH; Coppin CM; Gelmon KA; Jackson SM; Ragaz J; Wilson KS; Worth A
    N Engl J Med; 1994 Mar; 330(12):805-10. PubMed ID: 8114832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening and breast cancer.
    Baker SG
    N Engl J Med; 2006 Feb; 354(7):767-9; author reply 767-9. PubMed ID: 16481650
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer mortality after screening mammography in British Columbia women.
    Coldman A; Phillips N; Warren L; Kan L
    Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias when calculating breast cancer mortality after screening mammography in British Colombia.
    Zahl PH
    Int J Cancer; 2007 Jun; 120(11):2521; author reply 2522. PubMed ID: 17311262
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of relapse in breast cancer: changes over time.
    Yerushalmi R; Woods R; Kennecke H; Speers C; Knowling M; Gelmon K
    Breast Cancer Res Treat; 2010 Apr; 120(3):753-9. PubMed ID: 19701704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant systemic therapy and survival after breast cancer.
    Sankaranarayanan R; Black RJ
    N Engl J Med; 1994 Aug; 331(6):402-3; author reply 403-4. PubMed ID: 8028629
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
    Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
    Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy may improve survival of premenopausal women with breast cancer involving axillary lymph nodes.
    Longo DL
    Postgrad Med; 2005 Apr; 117(4):6. PubMed ID: 15842126
    [No Abstract]   [Full Text] [Related]  

  • 15. The case against the use of adjuvant chemotherapy in breast cancer.
    Mueller CB
    Bull Am Coll Surg; 1993 Jun; 78(6):25-31. PubMed ID: 10126540
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
    Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
    J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
    Pritchard KI
    J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy for breast cancer: modest but clinically important benefits.
    Foster RS
    Bull Am Coll Surg; 1993 Jun; 78(6):18-24. PubMed ID: 10126539
    [No Abstract]   [Full Text] [Related]  

  • 19. [What is the benefit of adjuvant therapy in breast cancer?].
    Sauer H
    Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple negative breast cancer: adjuvant chemotherapy effect on survival.
    Steponaviciene L; Lachej-Mikeroviene N; Smailyte G; Aleknavicius E; Meskauskas R; Didziapetriene J
    Adv Med Sci; 2011; 56(2):285-90. PubMed ID: 22112429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.